Skip to content

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

Preventive and Personalized Medicine (2021-2023)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05095155
Enrollment
400
Registered
2021-10-27
Start date
2022-04-01
Completion date
2023-01-20
Last updated
2023-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B Cell Leukemia, Lymphoma

Keywords

SNP

Brief summary

To search for a genetic marker of B-cell leukemias and lymphomas in children of Kazakh nationality, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with B-cell leukemias and lymphomas in children of Kazakh nationality and normal control will be performed.

Interventions

SNP analysis of the DNA obtained from peripheral blood sample

Sponsors

Asfendiyarov Kazakh National Medical University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years

Inclusion criteria

* ethnicity - Kazakhs in at least three generations * active disease or a history of B-line ALL or B-NHL, established on the basis of morphological, cytochemical, immunophenotypic or immunohistochemical research methods with confirmation of the fact of the disease in medical documentation * Signed voluntary informed consent of the legal representative to participate in the project

Exclusion criteria

* Children suffering from other types of malignant neoplasms * Children with B-linear leukemia and lymphomas with concomitant specified genetic and chromosomal diseases * Children of non-Kazakh nationality * Absence of signed informed consent or informed refusal of the legal representative to participate in the study before starting therapy

Design outcomes

Primary

MeasureTime frameDescription
Associated with B-cell lymphoma and B-cell acute lymphoblastic leukemia1 yearGenotype frequency of SNP in the study genes of participants and control participants.

Countries

Kazakhstan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026